Boston Scientific Corporation (FRA:BSX)

Market Cap	128.71B
Revenue (ttm)	16.24B
Net Income (ttm)	1.88B
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	68.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59
Average Volume	512
Open	87.40
Previous Close	88.20
Day's Range	87.40 - 87.40
52-Week Range	62.00 - 105.00
Beta	n/a
RSI	50.03
Earnings Date	Apr 23, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD